Skip to content

The effect of spirulina prebiotic sauce on patients with metabolic syndrome

Investigating the effect of spirulina prebiotic sauce on anthropometric indicators, lipid profile, fat liver index of cardiovascular patients with metabolic syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240817062782N1
Enrollment
44
Registered
2025-03-10
Start date
2025-03-10
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metabolic syndrome. Encounter for screening for nutritional, metabolic and other endocrine disorders

Interventions

Intervention 1: Intervention group: Individuals who, consume one 20-gram sachet of spirulina-containing prebiotic salad dressing daily for 8 weeks. Intervention 2: Control group: Individuals who, cons

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients diagnosed by a physician suffering from metabolic syndrome Premenopausal women using a reliable contraceptive method and postmenopausal women on stable hormone replacement therapy. The individual should either be a non-smoker or smoke fewer than 10 cigarettes per day. No use of oral contraceptives, estrogen, progesterone, corticosteroids, or insulin. No adherence to specific diets such as vegetarian, ketogenic, etc. Not suffering from metabolic disorders such as diabetes or uncontrolled thyroid disorders. Aged between 18 to 65 No regular consumption of dietary supplements or "functional foods" containing spirulina or probiotics No weight loss of more than 5% in the past 3 months No specific exercise regimen

Exclusion criteria

Exclusion criteria: Not living in Shiraz.

Design outcomes

Primary

MeasureTime frame
Weight. Timepoint: Before intervention and 2 months after the start of the intervention. Method of measurement: with an accuracy of 100 grams using scale.;Waist circumference. Timepoint: Before intervention and 2 months after the start of the intervention. Method of measurement: With accuracy of 0.1 cm, using sewing meter.;Body mass index (BMI). Timepoint: Before intervention and 2 months after the start of the intervention. Method of measurement: Automatically is calculated (weight / Height^2).;Serum levels of triglycerides. Timepoint: Before intervention and 2 months after the start of the intervention. Method of measurement: Blood tests are conducted at Dr. Kaviani's laboratory.;Serum levels of total cholesterol. Timepoint: Before intervention and 2 months after the start of the intervention. Method of measurement: Blood tests are conducted at Dr. Kaviani's laboratory.;Serum levels of LDL. Timepoint: Before intervention and 2 months after the start of the intervention. Method of measurement: Blood tests are conducted at Dr. Kaviani's laboratory.;Serum levels of HDL. Timepoint: Before intervention and 2 months after the start of the intervention. Method of measurement: Blood tests are conducted at Dr. Kaviani's laboratory.;Serum levels of gamma-glutamyl transferase (GGT). Timepoint: Before intervention and 2 months after the start of the intervention. Method of measurement: Blood tests are conducted at Dr. Kaviani's laboratory.;Fatty liver index. Timepoint: Before intervention and 2 months after the start of the intervention. Method of measurement: Using formula.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactshiva shokri

Shiraz University of Medical Sciences

78shivashokri78@gmail.com+98 71 3731 0111

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026